Your browser doesn't support javascript.
loading
Value of CYFRA21-1,NSE,CRP and SCCA in diagnosis of lung cancer / 中国免疫学杂志
Chinese Journal of Immunology ; (12): 396-400, 2015.
Article in Zh | WPRIM | ID: wpr-460367
Responsible library: WPRO
ABSTRACT
Objective:To investigate the applied value of serum Cyfra21-1,NSE,CRP and SCCA and pleural effusion Cyfra21-1, NSE in pathological types, clinical stages and combination detection for diagnosis of lung cancer.Methods: Based on chemiluminescence immunoassay,the levels of serum NSE,Cyfra21-1,SCCA,CRP and pleural effusion NSE,Cyfra21-1 in 100 patients with lung cancer (case group) and 50 patients with benign diseases(control group) were determined.Results:The positive rates of serum Cyfra21-1,NSE,SCCA and pleural effusion NSE,Cyfra21-1 were significantly higher in case group than those in control group ( P0.05).Conclusion:The serum NSE, Cyfra21-1, CRP, SCCA and pleural effusion NSE, Cyfra21-1 play an important role in the diagnosis of lung cancer and contribute to the pathological type and TNM stage of lung cancer, the combination detection of tumor markers is helpful for the early diagnosis of lung cancer.
Key words
Full text: 1 Database: WPRIM Type of study: Diagnostic_studies / Screening_studies Language: Zh Journal: Chinese Journal of Immunology Year: 2015 Document type: Article
Full text: 1 Database: WPRIM Type of study: Diagnostic_studies / Screening_studies Language: Zh Journal: Chinese Journal of Immunology Year: 2015 Document type: Article